21:20:52 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



Evitrade Health Systems Corp
Symbol EVA
Shares Issued 15,390,265
Close 2017-10-30 C$ 0.85
Market Cap C$ 13,081,725
Recent Sedar Documents

ORIGINAL: Evitrade Health Systems Announces Impairment Due to Passing of the Founder and Creator of the TULIP™ Technology

2017-10-30 19:45 ET - News Release

Evitrade Health Systems Announces Impairment Due to Passing of the Founder and Creator of the TULIP™ Technology



Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) announces that as a result of management’s review for the Company’s audit and financial statements for the year ended June 30, 2017, the Company has determined that its intellectual property and intangible asset is impaired due to the passing of the founder of the company providing the research and development of the TULIP™ Health System.

 

“It is with profound sadness that I am announcing the passing of Dr. Radu Leca, the founder, medical advisor, and lead scientist for the TULIP™ Health System.  I would like to express my deepest condolences to all of his family, friends and colleagues.  Radu was a great human being and a “genius” among geniuses, his sudden passing is a great loss to humanity and to healthcare.  I miss him dearly” said Sydney Au, CEO of Evitrade.

 

The Company anticipates filing its current annual audited financial statements and MD&A for the year ended June 30, 2017 along with the amended re-stated financial statements and MD&A for the year ended June 30, 2016, as previously announced on the August 25, 2017 news release, today.

 

About EVITRADE Health Systems Corporation

 

EVITRADE Health Systems Corporation (formerly Auxellence Health Corp.), (CSE: EVA, OTCQB: AXHLF), was founded in 2013 to provide online “digital healthcare” services for resolving common health problems. The current markets are weight-loss, high blood pressure, high blood glucose and heart arrhythmia.

 

Contact: Sydney Au, CEO

EVITRADE Health Systems Corporation

(formerly Auxellence Health Corporation)

Twitter: @evitradehealth or https://twitter.com/evitradehealth

Email:info@auxellence.com

Website:http://www.auxellence.com

CSE Micro-site:http://thecse.com/en/listings/technology/evitrade-health-systems-corp

US OTC Markets:http://www.otcmarkets.com/stock/AXHLF/news

 

Disclaimers – Forward Looking Statements

 

This news release contains forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and http://www.otcmarkets.com/stock/AXHLF/filings. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.



To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/Evitrade10302017.pdf

Source: EVITRADE Health Systems Corp. (CSE:EVA, OTCQB:AXHLF)

To follow EVITRADE Health Systems Corp. on your favorite social media platform or financial websites, please click on the icons below.


 

Maximum News Dissemination by FSCwire. http://www.fscwire.com

 

Copyright © 2017 Filing Services Canada Inc.





© 2024 Canjex Publishing Ltd. All rights reserved.